Somatostatin receptor subtypes in neuroe
β
S. Jonas; M. John; J. Boese-Landgraf; R. HΓ€ring; G. Prevost; F. Thomas; S. Rosew
π
Article
π
1995
π
Springer
π
English
β 841 KB
## Somatostatin receptor scintigraphy (SRS) is positive in approximately 80% of all patients who have been found to have neuroendocrine (NE) gastroenteropancreatic (GEP) tumors. The reasons for negative results are unclear. The aim of the present study was identification of the specific somatostat